Case Report: Can early full-course tocilizumab therapy reverse vascular stenosis in Takayasu arteritis?

Case Report: Can early full-course tocilizumab therapy reverse vascular stenosis in Takayasu arteritis?

Takayasu arteritis (TAK) is an idiopathic systemic disease characterized by granulomatous inflammation of the aorta and its branches. TAK can cause multiple vascular injuries throughout the body, mainly arterial stenosis and aneurysms. In severe cases, it can even lead to fatal hemorrhage, infarctio...

Full description

Saved in:
Bibliographic Details
Main Authors: Congqi Hu, Lingjie Liu, Hui Xiao, Hongjun Zhao, Guangxing Chen, Yanli Xie
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Immunology
Subjects:
Takayasu arteritis
tocilizumab
TNFi
vascular stenosis and recanalization
cure
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1593770/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items